Concept explainers
To determine: The possible genotypes of children born if a individual who is heterozygous for a recessive mutation in enzyme 1 and enzyme 2 marries an individual having the same genotype.
Introduction:

Explanation of Solution
It is given that both the individuals are heterozygous for a recessive mutation of enzymes 1 and 2. To find the possible genotypes of their children, genotypes of parents can be assumed as:
R represents normal enzyme 1 and r shows mutated enzyme 1. D shows normal enzyme 2 and d shows mutated enzyme 2.
Both the parents are heterozygous for the recessive mutation in both the enzymes. So the gametes produced by these parents will be RD, Rd, rD, and rd.
Genotype of the children from these gametes can be determined as follows:
RD | Rd | rD | rd | |
RD | RRDD | RRDd | RrDD | RrDd |
Rd | RRDd | RRdd | RrDd | Rrdd |
rD | RrDD | RrDd | rrDD | rrDd |
rd | RrDd | Rrdd | rrDd | rrdd |
GenotypesRRDD, RRDd, RrDD, RrDd, RRDd, RrDd, RrDD, RrDd, and RrDd will not show any mutation in any of the enzymes.
Genotypes rrDD, rrDd, and rrDd will show mutation in enzyme 1 only.
Genotypes RRdd, Rrdd, and Rrdd will show mutation in enzyme 2 only.
Genotype rrdd will show mutation in both the enzymes 1 and 2.
To determine: The activity ofenzyme 1 and enzyme 2 for all the genotypes that are produced in children if an individual who is heterozygous for a recessive mutation in both, enzyme 1 and enzyme 2, marries an individual having the same genotype, assuming that there is 0% activity for mutant alleles and 50% activity in normal alleles.
Introduction: Metabolic pathways are catalyzed using enzymes. These enzymes are synthesized based on information provided by the genes.. Any type of change in these genes can hinder the synthesis of these enzymes or lead to synthesis of faulty enzymes. Heterozygosity is when same copies of alleles are present for a gene and homozygosity is when different copies of alleles are present for a gene.

Explanation of Solution
The possible genotypes of children born from parents who are heterozygous for a recessive mutation in both the enzymes are determined as follows:
R represents normal enzyme 1 and r shows mutated enzyme 1. D shows normal enzyme 2 and d shows mutated enzyme 2.
Both the parents are heterozygous for the recessive mutation in both the enzymes. So the gametes produced by these parents will be RD, Rd, rD, and rd.
Genotype of the children from these gametes can be determined as follows:
RD | Rd | rD | rd | |
RD | RRDD | RRDd | RrDD | RrDd |
Rd | RRDd | RRdd | RrDd | Rrdd |
rD | RrDD | RrDd | rrDD | rrDd |
rd | RrDd | Rrdd | rrDd | rrdd |
Genotypes RRDD, RRDd, RrDD, RrDd, RRDd, RrDd, RrDD, RrDd, and RrDd will not show any mutation in any of the enzymes. Hence, both the enzymes will show 50% activity in these genotypes
Genotypes rrDD, rrDd, and rrDd will show mutation in enzyme 1 only. Hence, in children with these genotypes, enzyme 1 will show 0% activity and enzyme 2 will show 50 % activity.
Genotypes RRdd, Rrdd, and Rrdd will show mutation in enzyme 2 only. Hence, in children with these genotypes, enzyme 1 will show 50% activity and enzyme 2 will show 0% activity.
Genotype rrdd will show mutation in both the enzymes 1 and 2. Hence, in children with these genotypes, both, enzyme 1 and enzyme 2 will show 0% activity.
To determine: Whether compound C will be made or not in each genotype of children born, if an individual who is heterozygous for a recessive mutation in both, enzyme 1 and enzyme 2, marries an individual having the same genotype, and if compound C not produced, the compounds that will be in excess.
Introduction: Metabolic pathways are catalyzed using enzymes. These enzymes are synthesized based on information provided by the genes.. Any type of change in these genes can hinder the synthesis of these enzymes or lead to synthesis of faulty enzymes. Heterozygosity is when same copies of alleles are present for a gene and homozygosity is when different copies of alleles are present for a gene.

Explanation of Solution
Genotype RRDD will not show any mutation in any of the enzymes. So, all the compounds will be present in their adequate amounts.
Genotype RRDd will not show any mutation in any of the enzymes. So, all the compounds will be present in their adequate amounts.
Genotype RrDD will not show any mutation in any of the enzymes. So, all the compounds will be present in their adequate amounts
Genotype RrDd will not show any mutation in any of the enzymes. So, all the compounds will be present in their adequate amounts
Genotype RRDd will not show any mutation in any of the enzymes. So, all the compounds will be present in their adequate amounts
Genotype RRdd will show mutation in enzyme 2 only. Hence, compound C will not be produced while there will be an excess production of compound B. Compound A will be present in normal amounts.
Genotype RrDd will not show any mutation in any of the enzymes. So, all the compounds will be present in their adequate amounts
Genotype Rrdd will show mutation in enzyme 2 only. Hence, compound C will not be produced while there will be an excess production of compound B. Compound A will be present in normal amounts.
Genotype RrDD will not show any mutation in any of the enzymes. So, all the compounds will be present in their adequate amounts
Genotype RrDd will not show any mutation in any of the enzymes. So, all the compounds will be present in their adequate amounts
Genotype rrDD will show mutation in enzyme 1 only. So there will be no production of compound B as mutated enzyme 1 will not be able to act on compound A. Absence of compound B will cause no production of compound C. Here, compound A will be present in excess.
Genotype rrDd will show mutation in enzyme 1 only. So there will be no production of compound B as mutated enzyme 1 will not be able to act on compound A. Absence of compound B will cause no production of compound C. Here, compound A will be present in excess.
Genotype RrDd will not show any mutation in any of the enzymes. So, all the compounds will be present in their adequate amounts
Genotype Rrdd will show mutation in enzyme 2 only. Hence, compound C will not be produced while there will be an excess of compound B. Compound A will be present in normal amounts.
Genotype rrDd will show mutation in enzyme 1 only. So there will be no production of compound B as mutated enzyme 1 will not be able to act on compound A. Absence of compound B will cause no production of compound C. Here, compound A will be present in excess.
Genotype rrdd will show mutation in both, enzyme 1 and enzyme 2. Hence no compound will be metabolized and compound C will not be produced.
Want to see more full solutions like this?
Chapter 10 Solutions
Human Heredity: Principles and Issues
- Please indentify the unknown organismarrow_forward5G JA ATTC 3 3 CTIA A1G5 5 GAAT I I3 3 CTIA AA5 Fig. 5-3: The Eco restriction site (left) would be cleaved at the locations indicated by the arrows. However, a SNP in the position shown in gray (right) would prevent cleavage at this site by EcoRI One of the SNPs in B. rapa is found within the Park14 locus and can be detected by RFLP analysis. The CT polymorphism is found in the intron of the Bra013780 gene found on Chromosome 1. The Park14 allele with the "C" in the SNP has two EcoRI sites and thus is cleaved twice by EcoRI If there is a "T" in that SNP, one of the EcoRI sites is altered, so the Park14 allele with the T in the SNP has only one EcoRI site (Fig. 5-3). Park14 allele with SNP(C) Park14 allele with SNPT) 839 EcoRI 1101 EcoRI 839 EcoRI Fig. 5.4: Schematic restriction maps of the two different Park14 alleles (1316 bp long) of B. rapa. Where on these maps is the CT SNP located? 90 The primers used to amplify the DNA at the Park14 locus (see Fig. 5 and Table 3 of Slankster et…arrow_forwardFrom your previous experiment, you found that this enhancer activates stripe 2 of eve expression. When you sequence this enhancer you find several binding sites for the gap gene, Giant. To test how Giant interacts with eve, you decide to remove all of the Giant binding sites from the eve enhancer. What results do you expect to see with respect to eve expression?arrow_forward
- What experiment could you do to see if the maternal gene, bicoid, is sufficient to form anterior fates?arrow_forwardYou’re curious about the effect that gap genes have on the pair-rule gene, evenskipped (eve), so you isolate and sequence each of the eve enhancers. You’re particularly interested in one of the enhancers, which is just upstream of the eve gene. Describe an experimental technique you would use to find out where this particular eve enhancer is active.arrow_forwardFor short answer questions, write your answers on the line provided. To the right is the mRNA codon table to use as needed throughout the exam. First letter U บบบ U CA UUCPhe UUA UCU Phe UCC UUG Leu CUU UAU. G U UAC TV UGCys UAA Stop UGA Stop A UAG Stop UGG Trp Ser UCA UCG CCU] 0 CUC CUA CCC CAC CAU His CGU CGC Leu Pro CCA CAA Gin CGA Arg CUG CCG CAG CGG AUU ACU AAU T AUC lle A 1 ACC Thr AUA ACA AUG Mot ACG AGG Arg GUU GCU GUC GCC G Val Ala GAC Asp GGU GGC GUA GUG GCA GCG GAA GGA Gly Glu GAGJ GGG AACASH AGU Ser AAA1 AAG Lys GAU AGA CAL CALUCAO CAO G Third letter 1. (+7) Use the table below to answer the questions; use the codon table above to assist you. The promoter sequence of DNA is on the LEFT. You do not need to fill in the entire table. Assume we are in the middle of a gene sequence (no need to find a start codon). DNA 1 DNA 2 mRNA tRNA Polypeptide C Val G C. T A C a. On which strand of DNA is the template strand (DNA 1 or 2)?_ b. On which side of the mRNA is the 5' end (left or…arrow_forward
- 3. (6 pts) Fill in the boxes according to the directions on the right. Structure R-C R-COOH OH R-OH i R-CO-R' R R-PO4 R-CH3 C. 0 R' R-O-P-OH 1 OH H R-C-H R-N' I- H H R-NH₂ \H Name Propertiesarrow_forward4. (6 pts) Use the molecule below to answer these questions and identify the side chains and ends. Please use tidy boxes to indicate parts and write the letter labels within that box. a. How many monomer subunits are shown? b. Box a Polar but non-ionizable side chain and label P c. Box a Basic Polar side chain and label BP d. Box the carboxyl group at the end of the polypeptide and label with letter C (C-terminus) H H OHHO H H 0 HHO H-N-CC-N-C-C N-C-C-N-GC-OH I H-C-H CH2 CH2 CH2 H3C-C+H CH2 CH2 OH CH CH₂ C=O OH CH2 NH2arrow_forwardplease answer (A,B,C,D,E) questions with the asnwer choice provided below. thank you!arrow_forward
- Human Heredity: Principles and Issues (MindTap Co...BiologyISBN:9781305251052Author:Michael CummingsPublisher:Cengage LearningHuman Biology (MindTap Course List)BiologyISBN:9781305112100Author:Cecie Starr, Beverly McMillanPublisher:Cengage Learning
- Biology Today and Tomorrow without Physiology (Mi...BiologyISBN:9781305117396Author:Cecie Starr, Christine Evers, Lisa StarrPublisher:Cengage Learning


